🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaosheng Fang

Shandong Provincial Hospital

ORCID: 0000-0002-4515-9731

Also affiliated with Shandong First Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents”.

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0466

N/A

0DataRank · unranked

38 citations

Zijun Y. Xu‐Monette, Lan V. Pham, Xudong Wang, Alexandar Tzankov, Xiaosheng Fang +23 more

Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions

The Oncologist(2020)10.1002/onco.13605

N/A

0DataRank · unranked

5 citations

Zhongling Sun, Zijun Y. Xu‐Monette, Ken H. Young, Xiaosheng Fang

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

Neoplasia(2021)10.1016/j.neo.2021.02.002

N/A

0DataRank · unranked

29 citations

Vasantha Lakshmi Gali, Zijun Y. Xu‐Monette, Dahlia Sano, Sheeba K. Thomas, Donna M. Weber +10 more

Data from Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

(2023)10.1158/1078-0432.c.6532629.v1

N/A

0DataRank · unranked

0 citations

Li Wei, Xiaosheng Fang, Qingyan Au, Harry Nunns, Máté Nagy +26 more